Wake Forest University and Ameritox Ltd. said Tuesday they have formed a partnership aimed at furthering university chemistry research in developing technologies for medication monitoring and toxicology testing.
Ameritox provides laboratory services and management tools under the RxGuardian brand. The service helps assess whether patients are taking their pain medication consistent with the dosage prescribed by their doctors. It provides individual results by using the patient's height, weight, gender, age and prescribed dosage.
Christa Colyer, chairwoman of the university’s chemistry department, said having access to the Ameritox laboratory “will make it that much easier to collaborate and exchange ideas to realize testing breakthroughs.” Read more.